Skoltech is announcing a joint invention administration agreement (JIAA) with the Broad Institute of MIT and Harvard, and with Rutgers, The State University of New Jersey, to make jointly-developed intellectual property (IP) on CRISPR-Cas systems available to the commercial scientific and biotechnology communities. The IP is referred to C2c1 (Cas12b) and C2c2 (Cas13) systems that were discovered by Sergey Shmakov in 2015 in the course of his postgraduate studies at Skoltech supervised by professor Konstantin Severinov (the full text of the original article is available here).